BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Authors
» Aaron Lorenzo
Aaron Lorenzo
Articles
ARTICLES
NeoPharm, FDA Define Plans For IL13's Phase III Program
Feb. 9, 2004
By
Aaron Lorenzo
Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline
Feb. 6, 2004
By
Aaron Lorenzo
Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline
Feb. 6, 2004
By
Aaron Lorenzo
Caprion Pairs Proteomics-Based Lung Cancer Work With Abbott
Feb. 5, 2004
By
Aaron Lorenzo
Caprion Pairs Proteomics-Based Lung Cancer Work With Abbott
Feb. 5, 2004
By
Aaron Lorenzo
Liver Drug Developer Metabasis Files Registration For $86M IPO
Feb. 4, 2004
By
Aaron Lorenzo
Liver Drug Developer Metabasis Files Registration For $86M IPO
Feb. 4, 2004
By
Aaron Lorenzo
Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering
Feb. 3, 2004
By
Aaron Lorenzo
Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering
Feb. 3, 2004
By
Aaron Lorenzo
Palatin Raises $22.7M For Drug Trials Via Stock, Warrants Sale
Feb. 2, 2004
By
Aaron Lorenzo
View All Articles by Aaron Lorenzo
